Dynavax Technologies Corporation reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported revenue was USD 108.27 million compared to USD 13.41 million a year ago. Net loss was USD 28.43 million compared to net income of USD 4.4 million a year ago. Basic loss per share from continuing operations was USD 0.24 compared to basic earnings per share from continuing operations of USD 0.04 a year ago. Diluted loss per share from continuing operations was USD 0.24 compared to USD 0.15 a year ago. For the nine months, revenue was USD 244.37 million compared to USD 27 million a year ago. Net loss was USD 23.07 million compared to USD 59.77 million a year ago. Basic loss per share from continuing operations was USD 0.2 compared to USD 0.61 a year ago. Diluted loss per share from continuing operations was USD 0.2 compared to USD 0.65 a year ago.